# Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease

> **NCT00002714** · PHASE2 · COMPLETED · sponsor: **Stanford University**

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** Stanford V regimen
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** mechlorethamine hydrochloride
- **DRUG:** prednisone
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002714
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-04
- **Primary completion:** —
- **Final completion:** 2001-09
- **Target enrollment:** — (—)
- **Last updated:** 2013-05-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002714, "Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Early-Stage Hodgkin's Disease". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00002714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*